Page 222 - Index

Consolidated
Peter Lee is an Australian research and consulting firm providing benchmarking research programs to the financial
services sector. Peter Lee conducts annual research programs across Australia and New Zealand in various areas in
banking, markets and investment management. The acquisition will complement Crisil’s existing portfolio of products
and expand offerings to new geographies and segments across financial services including commercial banks and
investment management. The deal will accelerate Crisil’s strategy in the APAC region to be the foremost player in the
growing market.
The total consideration is C 3,421 lakh (AUD 6.18 million), which includes upfront and deferred consideration.
Assets acquired, and liabilities assumed is as under:
Particulars J lakh
Total identifiable assets (A) 2,746
Total identifiable liabilities (B) 1,019
Goodwill (C) 1,694
Total net assets (A-B+C) 3,421
45.5 Incorporation of Crisil Irevna Information Technology Colombia SAS
The Board of Directors of Crisil Irevna UK Limited, subsidiary of Crisil Limited has approved the incorporation of a
wholly owned subsidiary in the name of “Crisil Irevna Information Technology Colombia SAS” in Colombia to carry out
research, risk and analytics services. On October 25, 2023, the Certificate of Incorporation has been received from the
Chamber of Commerce (Colombia) in the name of “Crisil Irevna Information Technology Colombia SAS”.
45.6 Closure of Greenwich Associates Canada, ULC
Greenwich Associates Canada, ULC (subsidiary of Crisil Irevna US LLC) has been closed post receiving the requisite
approval of the competent authorities w.e.f July 31, 2023. The same has no impact on the consolidated financial results
of the Group.
46. Employee stock option scheme (ESOS)
The Group has formulated an ESOS based on which employees are granted options to acquire the equity shares of
the parent Company that vests in a graded manner. The options are granted at the closing market price prevailing on
the stock exchange, immediately prior to the date of grant. Details of the ESOS granted are as under :
Exercise
price
(J)
Vesting condition Exercise
period
Weighted
average price
(J)*
Particulars Date of grant Number
of options
granted
ESOS 2014 (3) 16-Dec-16 82,100 2,180.85 Vested equally in the period
within 2 years
734.46
of 3 to 5 years subject to
from date of
ESOS 2014 (4) 09-Mar-17 13,400 1,997.35 680.28
conditions
vesting
ESOS 2014 (5) 17-Jul-17 25,000 1,956.55 626.51
ESOS 2014 (6) 08-Jan-18 8,000 1,919.25 623.48
ESOS 2014 (7) 24-Jan-18 2,38,970 1,969.45 651.23
ESOS 2014 (8) 04-Apr-18 1,64,457 1,841.35 Vested equally in the period
within 2 years
410.12
of 1 to 3 years subject to
from date of
ESOS 2014 (9) 16-Apr-19 2,26,155 1,568.85 332.35
conditions
vesting
*Weighted average price of options as per Black-Scholes Option Pricing model at the grant date.
220 Annual Report 2024